MyChesCo on MSN3 个月
Windtree Therapeutics Publishes SEISMiC Phase 2b Trial Design for Cardiac Treatment
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the publication of its SEISMiC Phase 2b trial ...